Trial Profile
Phase II, Placebo Controlled, Parallel Group, Double Blind, Randomised, Multicentre Trial Comparing the Anastrozole (Arimidex) Placebo Combination to the Anastrozole - ZD1839 (Iressa) Combination as Neoadjuvant Treatment in Postmenopausal Women With Stage I-IIIB Breast Cancer and Oestrogen Receptor (ER) and/or Progesterone (PgR) Positive Tumours
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Anastrozole (Primary) ; Gefitinib
- Indications Breast cancer
- Focus Biomarker; Therapeutic Use
- Sponsors AstraZeneca
- 09 Jul 2008 New trial record.